UK markets close in 2 hours 59 minutes

Galectin Therapeutics, Inc. (GALT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.5000-0.0100 (-0.28%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
32,130
32,130
31,737
23,818
17,976
Selling general and administrative
5,942
5,942
6,615
6,361
5,468
Total operating expenses
38,072
38,072
38,352
30,179
23,444
Operating income or loss
-38,072
-38,072
-38,352
-30,179
-23,444
Interest expense
2,792
2,792
1,033
489
87
Total other income/expenses net
-432
-432
557
138
-
Income before tax
-41,066
-41,066
-38,776
-30,527
-23,465
Income from continuing operations
-41,066
-41,066
-38,776
-30,527
-23,465
Net income
-41,066
-41,066
-38,776
-30,527
-23,465
Net income available to common shareholders
-44,805
-44,805
-38,873
-30,698
-23,602
Basic EPS
-0.39
-0.74
-0.65
-0.52
-0.41
Diluted EPS
-0.39
-0.74
-0.65
-0.52
-0.41
Basic average shares
52,238
60,159
59,391
58,527
57,029
Diluted average shares
52,238
60,159
59,391
58,527
57,029